|
AVTX | Avalo Therapeutics, Inc. |
|
|
AVTX | Avalo Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.02 |
| Leverage | 76.91% |
| Market Cap | $ 1.4B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -121.3m |
| Margin | -50272.01% |
None